about
The Vivax Surveyor: Online mapping database for Plasmodium vivax clinical trialsMalaria in Brazil, Colombia, Peru and Venezuela: current challenges in malaria control and elimination.Dynamics of Plasmodium vivax sporogony in wild Anopheles stephensi in a malaria-endemic region of Western IndiaAn outbreak of locally acquired Plasmodium vivax malaria among migrant workers in Oman.Genetic diversity of Plasmodium vivax metacaspase 1 and Plasmodium vivax multi-drug resistance 1 genes of field isolates from Mauritania, Sudan and Oman.Demographic and clinical profiles of Plasmodium falciparum and Plasmodium vivax patients at a tertiary care centre in southwestern India.DARC extracellular domain remodeling in maturating reticulocytes explains Plasmodium vivax tropism.Malaria 2017: Update on the Clinical Literature and Management.Population-level estimates of the proportion of Plasmodium vivax blood-stage infections attributable to relapses among febrile patients attending Adama Malaria Diagnostic Centre, East Shoa Zone, Oromia, Ethiopia.CD36 receptor regulates malaria-induced immune responses primarily at early blood stage infection contributing to parasitemia control and resistance to mortality.Plasmodium vivax ligand-receptor interaction: PvAMA-1 domain I contains the minimal regions for specific interaction with CD71+ reticulocytes.A model of Plasmodium vivax concealment based on Plasmodium cynomolgi infections in Macaca mulattaProximity to vector breeding site and risk of Plasmodium vivax infection: a prospective cohort study in rural Ethiopia.Integrative analysis associates monocytes with insufficient erythropoiesis during acute Plasmodium cynomolgi malaria in rhesus macaques.Metabolome-wide association study of peripheral parasitemia in Plasmodium vivax malaria.Management of Plasmodium vivax risk and illness in travelers.Long-term in vitro culture of Plasmodium vivax isolates from Madagascar maintained in Saimiri boliviensis blood.In Vivo and In Vitro Activities and ADME-Tox Profile of a Quinolizidine-Modified 4-Aminoquinoline: A Potent Anti-P. falciparum and Anti-P. vivax Blood-Stage Antimalarial.Are respiratory complications of Plasmodium vivax malaria an underestimated problem?A randomized, double-blind, active-control trial to evaluate the efficacy and safety of a three day course of tafenoquine monotherapy for the treatment of Plasmodium vivax malaria.Primaquine ineligibility in anti-relapse therapy of Plasmodium vivax malaria: the problem of G6PD deficiency and cytochrome P-450 2D6 polymorphisms.Genomic Analyses Reveal the Common Occurrence and Complexity of Plasmodium vivax Relapses in Cambodia.Severe thrombocytopaenia in patients with vivax malaria compared to falciparum malaria: a systematic review and meta-analysis.Plasmodium vivax Infection in Duffy-Negative People in Africa.Genetic diversity of the Plasmodium vivax phosphatidylinositol 3-kinase gene in two regions of the China-Myanmar border.Sudden spleen rupture in a Plasmodium vivax-infected patient undergoing malaria treatment.Integrative metabolomics and transcriptomics signatures of clinical tolerance to Plasmodium vivax reveal activation of innate cell immunity and T cell signaling.Asymptomatic Plasmodium vivax parasitaemia in the low-transmission setting: the role for a population-based transmission-blocking vaccine for malaria elimination.Infection of Anopheles aquasalis from symptomatic and asymptomatic Plasmodium vivax infections in Manaus, western Brazilian Amazon.Analyzing the Local Epidemiological Profile of Malaria Transmission in the Brazilian Amazon Between 2010 and 2015.Implications of current therapeutic restrictions for primaquine and tafenoquine in the radical cure of vivax malaria.Strong selection during the last millennium for African ancestry in the admixed population of Madagascar.Relapsing Malaria: A Case Report of Primaquine Resistance.Multiplicity and molecular epidemiology of Plasmodium vivax and Plasmodium falciparum infections in East Africa.Malaria Elimination: Time to Target All Species.Bottom-up approach to strengthen community-based malaria control strategy from community health workers' perceptions of their past, present, and future: a qualitative study in Palawan, Philippines.Targeting a Reticulocyte Binding Protein and Duffy Binding Protein to Inhibit Reticulocyte Invasion by Plasmodium vivax.Unraveling the Plasmodium vivax sporozoite transcriptional journey from mosquito vector to human hostEpidemiology of Malaria Infection in NepalProjecting potential spatial and temporal changes in the distribution of Plasmodium vivax and Plasmodium falciparum malaria in China with climate change
P2860
Q30491343-2E8D1D69-78BC-43FC-9ABC-79EED77BDF5AQ33870033-7759E20B-22E1-4553-8463-3DB85F7B3710Q33891805-B8EFBFC1-3619-4404-B221-4A9C8D4373B7Q33893028-3675CA8B-46A0-4E02-94EF-933269F9BCC0Q36268240-A103F8C6-23CB-43E0-A402-8AE0286AD94EQ37440275-6A057609-4E24-42F1-88B8-7B51E0E4F88BQ38654415-BF12BAA8-DAB6-4184-84DB-2BDFFBB2591BQ38716255-1380E8E2-D23B-48F5-B3C2-95DE9366602AQ40105373-0E174222-616E-46B6-A717-E057E7ECDAACQ40248033-218451BE-ED22-4CA4-9479-4AC760657B20Q41566130-EEFE3865-0150-4932-8E45-592475915F52Q41693116-F166BA46-0EAF-4F21-89F3-F59110915F83Q41716192-D304534A-460F-495A-A429-DDA99D56AD1CQ41995142-35976D5D-B5CE-488F-A0CE-56B94C6B41DFQ41996386-351F1910-5A1F-425C-AD06-DB24EB50BFF3Q42338471-F6B6B93A-2924-4243-8D11-AC35917E3FBAQ43298292-1AAB527A-6AFB-4689-8576-5F44FC5F597DQ46250299-56804458-3E6C-41FC-952B-C78E07E050C6Q47144740-3EC9CD18-6C3E-4F66-B03C-30BC04E85147Q48015887-944E75C6-D2A9-4E68-BEC6-A9B4275B0466Q48022784-52B13BAB-1236-4213-AB5E-0B6468D3526AQ48023011-86E130D6-EA8B-4C36-A82F-222670B7C871Q49243362-B16796EC-945A-4272-A54D-D2A3D57D9D93Q49483873-EE4C5B19-2FD5-4FB2-8E49-B86502F8FDEFQ49807359-7B47E916-92B4-4635-BF40-4BB526688066Q50057933-8A3C0723-C980-4C10-B349-750DFDA2B761Q52308706-43F7EE8B-FA01-46B0-8B97-A24545E0DE44Q52375272-F0A054E9-EA4B-44F2-9DE0-E55AFD85EC06Q54220803-BF3A23D2-D4EB-4D43-8B12-2F2ABAB3F43AQ54986702-FDFD15DA-2168-4669-930B-198985C5A131Q55212289-9171FAFA-CE07-44A6-A939-4EB92E2E8F31Q55224247-E6460ABB-6A69-48B4-9FD9-CBC26527B17CQ55317242-9B7B6C88-F766-4613-8618-8647699E3FC3Q55339860-6C2AFD43-33F0-4D59-A435-B85072BC9B21Q55463707-8A1E00C3-CEFD-43E1-895C-57C8C2156E82Q55651110-3FA5EEB0-293A-4891-9CB3-0BF203608B8EQ55669690-40099F23-83EB-4D44-A638-FBE90E4E1F70Q56342580-EED63AB0-DC3E-49D6-887E-C29BB3416E77Q56361772-28E9866B-4B70-42BB-9CF0-C7530F77B019Q56830254-237CEB58-1DCE-4933-A257-79D5F6A84ACE
P2860
description
2016 nî lūn-bûn
@nan
2016 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2016 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
name
Global Epidemiology of Plasmodium vivax
@ast
Global Epidemiology of Plasmodium vivax
@en
type
label
Global Epidemiology of Plasmodium vivax
@ast
Global Epidemiology of Plasmodium vivax
@en
prefLabel
Global Epidemiology of Plasmodium vivax
@ast
Global Epidemiology of Plasmodium vivax
@en
P2860
P50
P921
P356
P1476
Global Epidemiology of Plasmodium vivax
@en
P2093
Richard E Cibulskis
Rosalind E Howes
P2860
P356
10.4269/AJTMH.16-0141
P407
P433
P5008
P577
2016-07-11T00:00:00Z
2016-12-28T00:00:00Z